Maternally transferred neutralising dengue antibodies in Thai infants: A pilot study

Annals of Tropical Paediatrics

Volumn 23, Issue 3, 2003, Pages 159-165

  Pengsaa, Krisana ^a   Yoksan, Sutee ^a   Limkittikul, Kriengsak ^a   Wisetsing, Pataraporn ^a   Sirivichayakul, Chukiat ^a   Hutacharoen, Pornsom ^b   Chanthavanich, Pornthep ^a   Sabchareon, Arunee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b RAJAVITHI HOSPITAL   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANTIBODY; CHILD HEALTH; DENGUE FEVER; DISEASE CONTROL;

ADULT; AGING; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFANT; MALE; MOTHER; PILOT STUDY; SENSITIVITY ANALYSIS; SEROTYPE; THAILAND; UMBILICAL CORD BLOOD; VIRUS NEUTRALIZATION; VIRUS TYPING;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; DENGUE; ENDEMIC DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HEMOLYTIC PLAQUE TECHNIQUE; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; THAILAND;

ASIA; EURASIA; SOUTHEAST ASIA; THAILAND;

EID: 0141737508     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1179/027249303322296466     Document Type: Article

References (20)

1. Pinheiro FP, Corber SJ. Global situation of dengue hemorrhagic fever and its emergence in the Americas. Wld Hlth Stat Q 1997; 50:161-9.
2. Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science 1988; 239:476-81.
3. Nimmannitya S. Dengue hemorrhagic fever: diagnosis and management. In: Gubler DJ, Kuno G, eds. Dengue and Dengue Haemorrhagic Fever. Wallingford, UK: CABI, 1997; 133-45.
4. Hongsiriwon S. Dengue hemorrhagic fever in infants. Southeast Asian J Trop Med Public Health 2002; 33:49-55.
5. Trong-Lân N, Thanh-Hung N, Bich Lien L. Clinical aspects of dengue hemorrhagic fever in infants less than one year old (Abstract, p. 43). In: 4th International Symposium on Dengue Fever, Tahiti, April 14-17, 1997.
6. Halstead SB, Scanlon JE, Umpaivit P, Udomsakdi S. Dengue and chikungunya virus infection in man in Thailand, 1962-1964. IV, Epidemiologic studies in Bangkok Metropolitan area. Am J Trop Med Hyg 1969; 18:997-1021.
7. Pancharoen C, Thisyakorn U. Dengue virus infection during infancy. Trans R Soc Trop Med Hyg 2001; 95:307-8.
8. Barnes WJS, Rosen L. Fatal hemorrhagic disease and shock associated with primary dengue infection on a Pacific island. Am J Trop Med Hyg 1974; 23:495-506.
9. Gubler DJ, Reed D, Rosen L, Hitchcock JR Jr. Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am J Trop Med Hyg 1978; 27:581-9.
10. Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988; 38:411-19.
11. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 1989; 40:444-51.
12. Sabchareon A, Lang J, Chanthavanich P, et al. Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio and multiple doses. Am J Trop Med Hyg 2002; 66:264-72.
13. Sabchareon A, Lang J, Chanthavanich P, et al. Safety evaluation of two tetravalent live-attenuated dengue vaccines in 5-12-year-old Thai children (Abstract 706). In: 50th Annual Meeting of the American Society of Tropical Medicine and Hygiene. Atlanta, GA: November 11-15, 2001.
14. Sabchareon A, Lang J, Yoksan S, et al. Immunogenicity of two tetravalent live-attenuated dengue vaccines in 5-12-year-old Thai children (Abstract 707). In: 50th Annual Meeting of the American Society of Tropical Medicine and Hygiene. Atlanta, GA: November 11-15, 2001.
15. Gans HA, Arvin AM, Galinus J, Logan L, De Hovitz R, Maldonado Y. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 1998; 280:527-32.
16. Russell PK, Nisalak A, Sukhavachana P, Vivona S. A plaque reduction test for dengue virus neutralising antibodies. J Immunol 1967; 99:285-90.
17. Clarke DH, Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropodborne viruses. Am J Trop Med Hyg 1958; 7:561-73.
18. Shu PY, Chen LK, Chang SF, et al. Dengue NS1-specific antibody response: isotype distribution and serotyping in patients with dengue fever and dengue hemorrhagic fever. J Med Virol 2000; 62:224-32.
19. Innis BL. Antibody responses to dengue virus infection. In: Gubler DJ, Kuno G, eds. Dengue and Dengue Haemorrhagic Fever. Wallingford, UK: CABI, 1997; 221-44.
20. Watanaveeradej V, Samakoses R, Kerdpanich A, et al. Transplacentally transferred dengue antibodies, subclasses and kinetics in Thai infants. Am J Trop Med Hyg 1999; 61:S211-12.